* Core Laboratories NV CLB.N reported quarterly adjusted
earnings of 12 cents per share for the quarter ended in June.
The mean expectation of eight analysts for the quarter was
for earnings of 14 cents per share.
* Revenue rose 1.8% to $120.90 million from a year ago;
analysts
expected $121.35 million.
* Core Laboratories NV's reported EPS for the quarter was 15
cents.
* The mean earnings estimate of analysts had fallen by
about 15.3%
in the last three months.
* In the last 30 days one analyst negatively revised an
earnings
estimate
* Core Laboratories NV shares had fallen by 12.8% this
quarter and
lost 22.5% so far this year.
* Wall Street's median 12-month price target for Core
Laboratories
NV is $23.00
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 4
"hold" and 2 "sell" or "strong sell."
This summary was machine generated from Refinitiv data July 27
at 11:21 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2022 0.14 0.12 Missed
Mar. 31 2022 0.09 0.08 Missed
Dec. 31 2021 0.20 0.20 Met
Sep. 30 2021 0.19 0.18 Missed